MSB 1.40% $1.09 mesoblast limited

Growing doubt on COVID-19 Application, page-63

  1. 7,855 Posts.
    lightbulb Created with Sketch. 619
    Also we are discussing theoretical ideas at face value
    Over the years it has amazed me that the stock market more than most is really a binary outcome Someone wins usually at the expense of another snd consequently people will do things that further that aim that might not necessarily be kosher
    When such big amounts of money on the line and MSB being the gift that keeps on giving the other side of the coin is motivated to push the line which enables their bet while retail basically has to go long (not all but most) Going long has meant you just have to hope the research for your investing hypothesis stacks up while the professionals can go long then go short then straddle all with the sweet heart no brokerage deal that they haveand then using algos bots and just plain lies to get their bet across the line It is what it is and over the years the only way to win I have surmised is to find a stock that you can build a big position in and then strap yourself in knowing it is going to be very rocky If things change you have to get out and dust yourself off I would hazard to say retail holders have a success rate of about 20% winners because they get pushed out of stocks At the moment I refuse to be pushed out of this stock because of the fear engendered by a post that asks where is Novartis?
    Last edited by stocksa: 16/08/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.015(1.40%)
Mkt cap ! $1.238B
Open High Low Value Volume
$1.11 $1.12 $1.08 $11.51M 10.52M

Buyers (Bids)

No. Vol. Price($)
2 17804 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 230637 5
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
$1.09
  Change
0.015 ( 1.85 %)
Open High Low Volume
$1.10 $1.12 $1.08 1937390
Last updated 15.59pm 03/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.